Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN)), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to provide...
The article MindMed Doses First Patients in Phase 1 MDMA Trial was originally published on Microdose. MindMed Collaborators Dose First Subject in Phase...
Any analyst knows that market-reactive swings aren’t really a true indicator of what is going on inside a company. The post Psychedelics Stock Swings...